1. 2022
  2. Identification of 2-(4-N,N-Dimethylaminophenyl)-5-methyl-1-phenethyl-1H-benzimidazole targeting HIV-1 CA capsid protein and inhibiting HIV-1 replication in cellulo

    Alvarez, G., van Pul, L., Robert, X., Artía, Z., van Nuenen, A. C., Long, M., Sierra, N., Porcal, W., Kootstra, N. A. & Guillon, C., 1 Dec 2022, In: BMC pharmacology & toxicology. 23, 1, 43.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study

    the RECoVERED Study Group, Dec 2022, In: BMC medicine. 20, 1, 422.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysis

    H-TEAM additional collaborators, HIV Transmission Elimination AMsterdam (H-TEAM) Initiative, The H-TEAM members are & H-TEAM Project Management, Dec 2022, In: The Lancet Regional Health - Europe. 23, 100515.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Antibody Response in Immunocompromised Patients with Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19

    Haggenburg, S., Hofsink, Q., Lissenberg-Witte, B. I., Broers, A. E. C., van Doesum, J. A., van Binnendijk, R. S., den Hartog, G., Bhoekhan, M. S., Haverkate, N. J. E., Burger, J. A., Bouhuijs, J. H., Smits, G. P., Wouters, D., van Leeuwen, E. M. M., Bontkes, H. J., Kootstra, N. A., Zweegman, S., Kater, A. P., Heemskerk, M. H. M., Groen, K., & 8 othersvan Meerten, T., Mutsaers, P. G. N. J., Beaumont, T., van Gils, M. J., Goorhuis, A., Rutten, C. E., Hazenberg, M. D. & Nijhof, I. S., Oct 2022, In: JAMA oncology. 8, 10, p. 1477-1483 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset

    RECoVERED Study Group, 24 Aug 2022, In: Clinical infectious diseases. 75, 1, p. e482-e490

    Research output: Contribution to journalArticleAcademicpeer-review

  7. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study

    the RECoVERED Study Group, 30 Jul 2022, In: Vaccine. 40, 32, p. 4424-4431 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B

    Erken, R., Loukachov, V., van Dort, K., van den Hurk, A., Takkenberg, R. B., de Niet, A., Jansen, L., Willemse, S., Reesink, H. & Kootstra, N., Jul 2022, In: Hepatology. 76, 1, p. 196-206 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Reply

    Loukachov, V. V., van Dort, K. A., Erken, R., Reesink, H. W. & Kootstra, N. A., Jul 2022, In: Hepatology. 76, 1, p. E24

    Research output: Contribution to journalComment/Letter to the editorAcademic

  10. Identification of Liver and Plasma microRNAs in Chronic Hepatitis B Virus infection

    Loukachov, V. V., van Dort, K. A., Maurer, I., Takkenberg, R. B., de Niet, A., Reesink, H. W., Willemse, S. B. & Kootstra, N. A., 2 Jun 2022, In: Frontiers in cellular and infection microbiology. 12, 790964.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Identification of a Novel HBV Encoded miRNA Using Next Generation Sequencing

    Loukachov, V., van Dort, K. A., Jansen, L., Reesink, H. W. & Kootstra, N. A., 1 Jun 2022, In: Viruses. 14, 6, 1223.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...20 Next

ID: 67029